Welcome to New Insights into HE, an educational website developed for hepatologists, gastroenterologists, doctors of internal medicine, physicians and other healthcare providers with an interest in improving the identification and management of patients with hepatic encephalopathy (HE).
Nurses and other healthcare providers may find some of this content appropriate, but are directed to the HEFastFacts area for non-accredited education which may be more appropriate as an introduction to this topic.
This website has eight core educational ‘Modules’ which were developed by the New
Insights Steering Committee faculty. These modules review the pathogenesis of HE,
the burden on patients and healthcare resources and appropriate diagnosis and management.
There are also interactive, case-based activities, to help you consider how you
will apply the information presented, and a summary of the must know literature
in the field.
Modules 1-7 will take approximately 20-30 minutes to complete. Module 8 will take approximately 60 minutes to complete, plus the time taken to evaluate the content and complete the post-activity test for each module.
Please also access the ‘Updates’ tab for updates and highlights of the latest data
which will ensure you remain informed and up-to-date about HE.
Instructions for use of this website
- The on-demand core educational modules can be accessed in any order
- Please review faculty disclosures in the ‘disclosures’ tab
- The complete list of modules is available on the ‘Modules’ tab. This will indicate
which modules you have successfully completed. On accessing the module please review
the short pre-activity information
- After completion of each module, and sucessfullly passing a short post-activity
test and your evaluation you will be able to access your certificate of completion
- Updates and guest activities, as well as links to useful resources and a ‘presentation
to go’ are available in the ‘Updates’ tab
Disclaimer: Use of medicinal products
according to approved indications
The educational content has been developed by an expert faculty and reflects up-to-date data and their clinical expertise. Some of the pharmaceutical products mentioned have approved indications which vary between countries and some therapies mentioned are not approved for the treatment of hepatic encephalopathy, or are not available in all countries.
When reviewing the content within this educational website, it is the responsibility of the learner to check the approved indications and recommended doses of any therapies mentioned.
The Summary of Product Characteristics (SPCs) for EMA CHMP-approved products can be found on the EMA website (http://www.ema.europa.eu/ema/), or from the relevant manufacturer. For users of this website based in the United Kingdom, current SPCs for most therapies can be found at https://www.medicines.org.uk/emc.
An application has been made to the EACCME© for CME accreditation of this